Cargando…

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma

Multiple Myeloma (MM) is an incurable malignancy with current treatment choices primarily comprising combination regimens implemented with a risk-adapted approach. Cereblon (CRBN)-targeting immunomodulatory agents (IMiDs(®)) lenalidomide (LEN) and pomalidomide (POM) play a central role in combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakurta, Anjan, Pierceall, William E., Amatangelo, Michael D., Flynt, Erin, Agarwal, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310669/ https://www.ncbi.nlm.nih.gov/pubmed/34316334 http://dx.doi.org/10.18632/oncotarget.27973

Ejemplares similares

Multiple Myeloma Patient Tumors With High Levels of Cereblon Exon-10 Deletion Splice Variant Upregulate Clinically Targetable Pro-Inflammatory Cytokine Pathways
por: Karagoz, Kubra, et al.
Publicado: (2022)

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
por: Bjorklund, Chad C., et al.
Publicado: (2019)

Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
por: Flynt, Erin, et al.
Publicado: (2020)

P865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL
por: Amatangelo, M., et al.
Publicado: (2022)

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma
por: Gooding, Sarah, et al.
Publicado: (2022)

Differential RNA splicing as a potentially important driver mechanism in multiple myeloma
por: Bauer, Michael A., et al.
Publicado: (2020)

Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways
por: Ortiz-Estévez, María, et al.
Publicado: (2021)

Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
por: Sudha, Parvathi, et al.
Publicado: (2022)

Central Neurotoxicity of Immunomodulatory Drugs in Multiple Myeloma
por: Patel, Urmeel H., et al.
Publicado: (2015)

Adherence to immunomodulatory drugs in patients with multiple myeloma
por: Cransac, Amélie, et al.
Publicado: (2019)

Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
por: Hideshima, T, et al.
Publicado: (2015)

The Next Generation Becomes the Now Generation
por: Martinez, Diego A., et al.
Publicado: (2010)

Training the Next Generation
por: Schwartz, David A.
Publicado: (2005)

Immunomodulatory Agents for Multiple Myeloma
por: Minařík, Jiří, et al.
Publicado: (2022)

The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM
por: Stong, Nicholas, et al.
Publicado: (2023)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma
por: Chen, Lucia Y., et al.
Publicado: (2022)

Next generation drug connectivity mapping for acquiring therapeutic agents to differentially regulate myelination
por: Azim, Kasum, et al.
Publicado: (2022)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

The next generation of natural history collections
por: Schindel, David E., et al.
Publicado: (2018)

Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma
por: Ansari-Pour, Naser, et al.
Publicado: (2023)

Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing
por: Piazzi, Manuela, et al.
Publicado: (2023)

Managing and Analyzing Next-Generation Sequence Data
por: Richter, Brent G., et al.
Publicado: (2009)

Next‐generation conservation genetics and biodiversity monitoring
por: Hunter, Margaret E., et al.
Publicado: (2018)

Regenerative medicine curriculum for next-generation physicians
por: Wyles, Saranya P., et al.
Publicado: (2019)

Toward next-generation fuel cell materials
por: Shah, M.A.K. Yousaf, et al.
Publicado: (2023)

Metasurfaces for next-generation wireless communication systems
por: Ra’di, Younes, et al.
Publicado: (2023)

Optimizing carfilzomib use in multiple myeloma treatment
por: Yoon, Sung-Soo
Publicado: (2019)

Steps towards a Multiple Myeloma Cure?
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Deciphering next-generation pharmacogenomics: an information technology perspective
por: Potamias, George, et al.
Publicado: (2014)

Next-Generation Prosthetic Hand: from Biomimetic to Biorealistic
por: Lan, Ning, et al.
Publicado: (2021)

Towards Artificial Intelligence Applications in Next Generation Cytopathology
por: Giarnieri, Enrico, et al.
Publicado: (2023)

Multiple myeloma in Korea: risk stratification and initial treatment
por: Yoon, Sung-Soo
Publicado: (2018)

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
por: Anderson, Kenneth C., et al.
Publicado: (2021)

Creating next-generation microscopists: structural and molecular biology at the crossroads
por: Braet, F, et al.
Publicado: (2007)

Next-Generation High-Throughput Functional Annotation of Microbial Genomes
por: Baric, Ralph S., et al.
Publicado: (2016)

In the Age of Synthetic Biology, Will Antimicrobial Peptides be the Next Generation of Antibiotics?
por: Jaumaux, Félix, et al.
Publicado: (2020)

Nucleocapsid as a next-generation COVID-19 vaccine candidate
por: Oronsky, Bryan, et al.
Publicado: (2022)

Catalyzing next-generation Artificial Intelligence through NeuroAI
por: Zador, Anthony, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_49s1heeuhvb9k956nvqfb3glk2